Addition of rituximab to DA-EPOCH negated need for radiotherapy in primary ... Healio The addition of rituximab to dose-adjusted etoposide, doxorubicin, and cyclophosphamide plus vincristine and prednisone prevented the need for radiotherapy in most patients with primary mediastinal B-cell lymphoma, according to results of a phase 2, ... |
